Following a common theme of Hepatitis C-related stocks running together, Achillion...


Following a common theme of Hepatitis C-related stocks running together, Achillion Pharmaceuticals (ACHN +12.1%) rallies strongly after Israel-based BioLineRX announces a major development deal. Other Hep-C players to watch: INHX, IDIX, VRTX.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs